StockData
Anixa Biosciences Inc logo

Anixa Biosciences Inc (ANIX) stock

ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 6/30
$2.67+0.12 (+4.71%)

Close on Nov 17, 2026Market cap $92.82MP/E –Yield –

Anixa Biosciences cash

Cash and short-term investments held at the end of each period.

Anixa Biosciences's cash was $13.86M at Jul 31, 2026. For fiscal 2025 it was $15.17M, down 23.8% from the year before. Over ten years it grew 8.4% a year on average. The highest annual figure on record is $35.73M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Oct 31, 2025$15.17M-23.8%
FY2024Oct 31, 2024$19.92M-16.4%
FY2023Oct 31, 2023$23.84M-19.7%
FY2022Oct 31, 2022$29.69M-16.9%
FY2021Oct 31, 2021$35.73M+294.5%
FY2020Oct 31, 2020$9.06M+55.0%
FY2019Oct 31, 2019$5.84M+15.5%
FY2018Oct 31, 2018$5.06M-26.1%
FY2017Oct 31, 2017$6.84M+111.2%
FY2016Oct 31, 2016$3.24M-52.2%
FY2015Oct 31, 2015$6.77M+15.5%
FY2014Oct 31, 2014$5.86M+552.7%
FY2013Oct 31, 2013$898.00K+6.9%
FY2012Oct 31, 2012$840.00K-72.2%
FY2011Oct 31, 2011$3.02M+176.3%
FY2010Oct 31, 2010$1.09M-24.6%
FY2009Oct 31, 2009$1.45M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jul 31, 2026$13.86M-13.5%
Q2 FY2026CQ1 2026Apr 30, 2026$13.69M-12.3%
Q1 FY2026CQ4 2025Jan 31, 2026$14.20M-17.7%
Q4 FY2025CQ3 2025Oct 31, 2025$15.17M-23.8%
Q3 FY2025CQ2 2025Jul 31, 2025$16.03M-22.7%
Q2 FY2025CQ1 2025Apr 30, 2025$15.60M-32.9%
Q1 FY2025CQ4 2024Jan 31, 2025$17.26M-27.5%
Q4 FY2024CQ3 2024Oct 31, 2024$19.92M-16.4%
Q3 FY2024CQ2 2024Jul 31, 2024$20.75M-18.8%
Q2 FY2024CQ1 2024Apr 30, 2024$23.24M-13.9%
Q1 FY2024CQ4 2023Jan 31, 2024$23.80M-14.1%
Q4 FY2023CQ3 2023Oct 31, 2023$23.84M-19.7%
Q3 FY2023CQ2 2023Jul 31, 2023$25.53M-19.4%
Q2 FY2023CQ1 2023Apr 30, 2023$26.98M-16.3%
Q1 FY2023CQ4 2022Jan 31, 2023$27.70M-19.8%
Q4 FY2022CQ3 2022Oct 31, 2022$29.69M-16.9%
Q3 FY2022CQ2 2022Jul 31, 2022$31.66M-13.5%
Q2 FY2022CQ1 2022Apr 30, 2022$32.23M-15.4%
Q1 FY2022CQ4 2021Jan 31, 2022$34.53M+146.9%
Q4 FY2021CQ3 2021Oct 31, 2021$35.73M+294.5%
Q3 FY2021CQ2 2021Jul 31, 2021$36.62M+303.9%
Q2 FY2021CQ1 2021Apr 30, 2021$38.10M+591.7%
Q1 FY2021CQ4 2020Jan 31, 2021$13.98M+145.7%
Q4 FY2020CQ3 2020Oct 31, 2020$9.06M+55.0%
Q3 FY2020CQ2 2020Jul 31, 2020$9.07M+39.6%
Q2 FY2020CQ1 2020Apr 30, 2020$5.51M-16.2%
Q1 FY2020CQ4 2019Jan 31, 2020$5.69M-3.6%
Q4 FY2019CQ3 2019Oct 31, 2019$5.84M+15.5%
Q3 FY2019CQ2 2019Jul 31, 2019$6.50M+21.6%
Q2 FY2019CQ1 2019Apr 30, 2019$6.57M+21.2%
Q1 FY2019CQ4 2018Jan 31, 2019$5.90M+7.4%
Q4 FY2018CQ3 2018Oct 31, 2018$5.06M-26.1%
Q3 FY2018CQ2 2018Jul 31, 2018$5.34M-12.2%
Q2 FY2018CQ1 2018Apr 30, 2018$5.42M+5.8%
Q1 FY2018CQ4 2017Jan 31, 2018$5.50M+174.8%
Q4 FY2017CQ3 2017Oct 31, 2017$6.84M+111.2%
Q3 FY2017CQ2 2017Jul 31, 2017$6.09M–
Q2 FY2017CQ1 2017Apr 30, 2017$5.13M–
Q1 FY2017CQ4 2016Jan 31, 2017$2.00M–
Q4 FY2016CQ3 2016Oct 31, 2016$3.24M–

More Anixa Biosciences figures

See a number that looks wrong?